Drug Profile
Tecalcet
Alternative Names: KRN 568; Norcalin; NPS R 568; R 568Latest Information Update: 22 Nov 2000
Price :
$50
*
At a glance
- Originator NPS Pharmaceuticals
- Developer Kirin Brewery; NPS Pharmaceuticals
- Class Antirheumatics; Osteoporosis therapies; Small molecules
- Mechanism of Action Calcium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hyperparathyroidism; Osteitis; Postmenopausal osteoporosis; Rheumatic disorders
Most Recent Events
- 22 Nov 2000 Discontinued-II for Hyperparathyroidism in Japan (PO)
- 22 Nov 2000 Discontinued-II for Hyperparathyroidism in USA (PO)
- 22 Nov 2000 Discontinued-II for Postmenopausal osteoporosis (PO)